Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ruth Harvey

Showing results (51-60 of 68) with videos related to

Pageof 7
Sort By:
Plos Pathogens|December 10, 2021
Correction: Breadth and function of antibody response to acute SARS-CoV-2 infection in humansKuan-Ying A Huang, Tiong Kit Tan, Ting-Hua Chen, et al.
BMJ Neurology Open|December 22, 2025
Immunogenicity of three-dose COVID-19 vaccines in people living with multiple sclerosisMarianne J Shawe-Taylor, David Greenwood, Anna He, et al.
Med (New York, N.Y.)|August 20, 2021
Favorable antibody responses to human coronaviruses in children and adolescents with autoimmune rheumatic diseasesClaire T Deakin, Georgina H Cornish, Kevin W Ng, et al.
Nature Medicine|May 27, 2021
Cytokine release syndrome in a patient with colorectal cancer after vaccination with BNT162b2Lewis Au, Annika Fendler, Scott T C Shepherd, et al.
The Journal of Infection|August 23, 2025
Third exposure to COVID-19 infection or vaccination differentially impacts T cell responsesGift Ahimbisibwe, David Greenwood, Katalin Andrea Wilkinson, et al.
The Journal of Infection|September 11, 2022
Antibody correlates of protection from SARS-CoV-2 reinfection prior to vaccination: A nested case-control within the SIREN studyAna Atti, Ferdinando Insalata, Edward J Carr, et al.
Plos One|March 21, 2024
COVID-19 in non-hospitalised adults caused by either SARS-CoV-2 sub-variants Omicron BA.1, BA.2, BA.4/5 or Delta associates with similar illness duration, symptom severity and viral kinetics, irrespective of vaccination historyHermaleigh Townsley, Joshua Gahir, Timothy W Russell, et al.
Journal of Virological Methods|January 25, 2022
Detection and quantification of antibody to SARS CoV 2 receptor binding domain provides enhanced sensitivity, specificity and utilityCarolina Rosadas, Maryam Khan, Eleanor Parker, et al.
The Lancet. Infectious Diseases|September 14, 2024
Real-time estimation of immunological responses against emerging SARS-CoV-2 variants in the UK: a mathematical modelling studyTimothy W Russell, Hermaleigh Townsley, Joel Hellewell, et al.
Vaccine|January 5, 2011
The development of vaccine viruses against pandemic A(H1N1) influenzaJames S Robertson, Carolyn Nicolson, Ruth Harvey, et al.
Pageof 7

Showing results (51-60 of 68) with videos related to

Sort By:
Pageof 7
Plos Pathogens|December 10, 2021
Correction: Breadth and function of antibody response to acute SARS-CoV-2 infection in humansKuan-Ying A Huang, Tiong Kit Tan, Ting-Hua Chen, et al.
BMJ Neurology Open|December 22, 2025
Immunogenicity of three-dose COVID-19 vaccines in people living with multiple sclerosisMarianne J Shawe-Taylor, David Greenwood, Anna He, et al.
Med (New York, N.Y.)|August 20, 2021
Favorable antibody responses to human coronaviruses in children and adolescents with autoimmune rheumatic diseasesClaire T Deakin, Georgina H Cornish, Kevin W Ng, et al.
Nature Medicine|May 27, 2021
Cytokine release syndrome in a patient with colorectal cancer after vaccination with BNT162b2Lewis Au, Annika Fendler, Scott T C Shepherd, et al.
The Journal of Infection|August 23, 2025
Third exposure to COVID-19 infection or vaccination differentially impacts T cell responsesGift Ahimbisibwe, David Greenwood, Katalin Andrea Wilkinson, et al.
The Journal of Infection|September 11, 2022
Antibody correlates of protection from SARS-CoV-2 reinfection prior to vaccination: A nested case-control within the SIREN studyAna Atti, Ferdinando Insalata, Edward J Carr, et al.
Plos One|March 21, 2024
COVID-19 in non-hospitalised adults caused by either SARS-CoV-2 sub-variants Omicron BA.1, BA.2, BA.4/5 or Delta associates with similar illness duration, symptom severity and viral kinetics, irrespective of vaccination historyHermaleigh Townsley, Joshua Gahir, Timothy W Russell, et al.
Journal of Virological Methods|January 25, 2022
Detection and quantification of antibody to SARS CoV 2 receptor binding domain provides enhanced sensitivity, specificity and utilityCarolina Rosadas, Maryam Khan, Eleanor Parker, et al.
The Lancet. Infectious Diseases|September 14, 2024
Real-time estimation of immunological responses against emerging SARS-CoV-2 variants in the UK: a mathematical modelling studyTimothy W Russell, Hermaleigh Townsley, Joel Hellewell, et al.
Vaccine|January 5, 2011
The development of vaccine viruses against pandemic A(H1N1) influenzaJames S Robertson, Carolyn Nicolson, Ruth Harvey, et al.
Pageof 7